feed,title,long_url,short_url
Benzinga,"US Biosimilars Market to Rise at a Staggering 46.2% CAGR and Hit USD 22,996 Million till 2027; Breakthrough Concepts in Treatment of Severe Diseases will Bode Well for Market Growth, says Fortune Business Insightsâ„¢",https://www.benzinga.com/pressreleases/21/01/g19250695/us-biosimilars-market-to-rise-at-a-staggering-46-2-cagr-and-hit-usd-22-996-million-till-2027-break,https://j.mp/3o3KRwA
